Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, established in 1992, is a key player in the Medical Devices & Equipment and Manufacturing industries. The company focuses on the development and manufacturing of a comprehensive range of surgical instruments, catering to private label, branded, and OEM markets. Its product portfolio prominently features essential surgical supplies such as sutures and blades, underscoring its role in providing critical tools for medical professionals. The firm's strategic operations are centered around delivering high-quality medical components.

Angiotech Pharmaceuticals demonstrates significant operational scale, managing a network of 9 distinct locations. The company reports a substantial revenue of $489.5M, reflecting its market penetration and product demand. Its workforce comprises between 1,000-5,000 employees, indicating a robust operational capacity capable of supporting extensive manufacturing processes and global distribution efforts. This employee range signifies a substantial organizational structure dedicated to its specialized production.

Navigating a competitive landscape, Angiotech Pharmaceuticals is positioned among notable industry competitors including Edwards Lifesciences, Boston Scientific, and ABIOMED. The company's success is underpinned by its skilled workforce and commitment to innovation. For a deeper understanding of the individuals contributing to its strategic direction and operational execution, one can explore Meet Angiotech Pharmaceuticals's team. This provides a window into the human capital driving the company's ongoing development and market presence in the medical device sector.